Hierarchical clustering of ALK+ versus CD3+ cells (31,580 CpG sites) resulted in a distinct ALK+ cluster (except for one tumor) that appeared more distant to ALK− and CD3+ T cell samples because of a higher number of hypomethylated MVPs in ALK+ tumors (Figure 1B). This evidence concerns the gene ALK and neoplasm.